MRNA Jan 2025 200.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
At close: 03:02PM EDT
Loading interactive chart…
- Simply Wall St.
Moderna First Quarter 2024 Earnings: Beats Expectations
Moderna ( NASDAQ:MRNA ) First Quarter 2024 Results Key Financial Results Revenue: US$167.0m (down 91% from 1Q 2023...
- GuruFocus.com
Moderna Inc (MRNA) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges with ...
Despite a significant revenue drop, Moderna showcases robust clinical progress and strategic collaborations.
- Fortune
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
The drugmaker is optimistic about higher sales with new vaccines and a little help from AI in the coming years.
© 2024 Yahoo. All rights reserved.